{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:34:56Z","timestamp":1792002896110,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473976, 82273976, and 82073896"],"award-info":[{"award-number":["82473976, 82273976, and 82073896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Major Project Foundation of China","award":["2025ZD01904305"],"award-info":[{"award-number":["2025ZD01904305"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515012676"],"award-info":[{"award-number":["2024A1515012676"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY23H280001"],"award-info":[{"award-number":["LY23H280001"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>The latency of human immunodeficiency virus type 1 (HIV-1) is a major barrier to achieving an HIV-1 cure, as antiretroviral therapy does not target the latent virus. Virus-host interactions play an essential role in various stages of the HIV-1 lifecycle. Exploring the interaction between host factors and HIV-1 infection is critical for developing new HIV-1 treatment strategies. Yes-associated protein (YAP) is a key co-transcription factor in the Hippo signaling pathway, which regulates the occurrence and development of various diseases, including cellular metabolism, cancer, immunity, and viral infection. In this study, we first confirmed that YAP gene expression in patients with acquired immune deficiency syndrome (AIDS) was significantly lower than that in the healthy control group, as determined using the GEO2R online tool. Furthermore, YAP was identified as a negative regulator of HIV-1 transcription by mediating K33- and K48-linked ubiquitination and proteasomal degradation of Tat. Here, we further confirmed that the YAP TAD domain recruited ubiquitin-like with PHD and RING finger domain 1 (UHRF1) to mediate Tat\u2019s ubiquitination and degradation by the screening of the BioGRID database combined with IP-MS analysis. The conserved lysine residues K28, K29, and K41 on Tat were critical acceptor sites for ubiquitination and proteasomal degradation. Our findings revealed that YAP promotes the suppression of HIV-1 transcription and the maintenance of HIV-1 latency, providing novel insights into virus-host interactions for regulating HIV-1 latency.<\/jats:p>","DOI":"10.1371\/journal.ppat.1013906","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:42:38Z","timestamp":1769798558000},"page":"e1013906","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["YAP Inhibits HIV-1 transcription and promotes HIV-1 latency by regulating E3 ubiquitin ligase UHRF1 mediated tat degradation"],"prefix":"10.1371","volume":"22","author":[{"given":"Chenliang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muye","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huba Khamis","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-3121","authenticated-orcid":true,"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"5341","key":"ppat.1013906.ref001","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"D Finzi","year":"1997","journal-title":"Science"},{"issue":"6","key":"ppat.1013906.ref002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"issue":"16","key":"ppat.1013906.ref003","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel","volume":"324","author":"MS Saag","year":"2020","journal-title":"JAMA"},{"issue":"546","key":"ppat.1013906.ref004","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2254","article-title":"An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells","volume":"12","author":"Q Wang","year":"2020","journal-title":"Sci Transl Med"},{"key":"ppat.1013906.ref005","first-page":"100263","article-title":"Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation","volume":"7","author":"L Sun","year":"2024","journal-title":"Curr Res Microb Sci"},{"issue":"1","key":"ppat.1013906.ref006","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41467-022-29346-w","article-title":"A functional map of HIV-host interactions in primary human T cells","volume":"13","author":"J Hiatt","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"ppat.1013906.ref007","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1093\/nar\/gkac464","article-title":"Genome-wide CRISPR\/Cas9 transcriptional activation screen identifies a histone acetyltransferase inhibitor complex as a regulator of HIV-1 integration","volume":"50","author":"Q Zhang","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"7381","key":"ppat.1013906.ref008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature10719","article-title":"Global landscape of HIV-human protein complexes","volume":"481","author":"S J\u00e4ger","year":"2011","journal-title":"Nature"},{"issue":"8","key":"ppat.1013906.ref009","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/molbev\/msr065","article-title":"The evolutionary history of YAP and the hippo\/YAP pathway","volume":"28","author":"D Hilman","year":"2011","journal-title":"Mol Biol Evol"},{"issue":"1","key":"ppat.1013906.ref010","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1038\/s41467-024-49965-9","article-title":"The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer","volume":"15","author":"MR Patterson","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"ppat.1013906.ref011","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/liv.15628","article-title":"Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection","volume":"43","author":"X Luo","year":"2023","journal-title":"Liver Int"},{"issue":"5","key":"ppat.1013906.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010505","article-title":"Influenza A virus NS1 protein hijacks YAP\/TAZ to suppress TLR3-mediated innate immune response","volume":"18","author":"Q Zhang","year":"2022","journal-title":"PLoS Pathog"},{"issue":"27","key":"ppat.1013906.ref013","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1038\/onc.2014.281","article-title":"Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway","volume":"34","author":"G Liu","year":"2015","journal-title":"Oncogene"},{"issue":"8","key":"ppat.1013906.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009783","article-title":"Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells","volume":"17","author":"N Van Sciver","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1013906.ref015","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1038\/s41467-024-51356-z","article-title":"Hippo signaling pathway regulates Ebola virus transcription and egress","volume":"15","author":"J Liang","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"ppat.1013906.ref016","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ajpath.2019.12.005","article-title":"Hippo Signaling Pathway Has a Critical Role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation","volume":"190","author":"Jr Garcia G","year":"2020","journal-title":"Am J Pathol"},{"issue":"9","key":"ppat.1013906.ref017","article-title":"YAP suppresses human T-cell leukemia virus type 1 transcription","volume":"95","author":"H Li","year":"2023","journal-title":"J Med Virol"},{"issue":"12","key":"ppat.1013906.ref018","article-title":"YAP inhibits HCMV replication by impairing STING-mediated nuclear transport of the viral genome","volume":"18","author":"JH Lee","year":"2022","journal-title":"PLoS Pathog"},{"issue":"9","key":"ppat.1013906.ref019","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115316119","article-title":"HTLV-1 activates YAP via NF-kappaB\/p65 to promote oncogenesis","volume":"119","author":"T Zhao","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ppat.1013906.ref020","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/s12276-024-01316-w","article-title":"YAP promotes global mRNA translation to fuel oncogenic growth despite starvation","volume":"56","author":"D Hwang","year":"2024","journal-title":"Exp Mol Med"},{"issue":"1","key":"ppat.1013906.ref021","first-page":"149","article-title":"Lipid kinase PIP5K\u03b1?contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1. Cell communication and signaling:","volume":"21","author":"TPH Le","year":"2023","journal-title":"CCS"},{"issue":"1","key":"ppat.1013906.ref022","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1038\/s41467-020-17145-0","article-title":"The ataxin-1 interactome reveals direct connection with multiple disrupted nuclear transport pathways","volume":"11","author":"S Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"11","key":"ppat.1013906.ref023","first-page":"1712","article-title":"YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury","volume":"39","author":"M Qiu","year":"2023","journal-title":"Can J Cardiol"},{"issue":"17","key":"ppat.1013906.ref024","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-23-4034","article-title":"Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis","volume":"84","author":"Y Shu","year":"2024","journal-title":"Cancer Res"},{"key":"ppat.1013906.ref025","doi-asserted-by":"crossref","first-page":"45394","DOI":"10.1038\/srep45394","article-title":"PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription","volume":"7","author":"TB Faust","year":"2017","journal-title":"Sci Rep"},{"key":"ppat.1013906.ref026","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1742-4690-6-50","article-title":"What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?","volume":"6","author":"GR Campbell","year":"2009","journal-title":"Retrovirology"},{"issue":"1","key":"ppat.1013906.ref027","article-title":"Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle\u2019s dynamics and signaling","volume":"3","author":"W Li","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1013906.ref028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.118.313143","article-title":"YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6","volume":"123","author":"Y Lv","year":"2018","journal-title":"Circ Res"},{"issue":"3","key":"ppat.1013906.ref029","article-title":"Enhanced NF-\u03baB activation via HIV-1 Tat-TRAF6 cross-talk","volume":"10","author":"Y Li","year":"2024","journal-title":"Sci Adv"},{"issue":"14","key":"ppat.1013906.ref030","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1042\/BCJ20160825","article-title":"HIV-1 Tat potently stabilises Mdm2 and enhances viral replication","volume":"474","author":"R Raja","year":"2017","journal-title":"Biochem J"},{"issue":"4","key":"ppat.1013906.ref031","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01625-21","article-title":"UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat","volume":"12","author":"T Liang","year":"2021","journal-title":"Mbio"},{"key":"ppat.1013906.ref032","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fcell.2020.00735","article-title":"Role of YAP\/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways","volume":"8","author":"BC Heng","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"ppat.1013906.ref033","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5483\/BMBRep.2018.51.3.015","article-title":"DNA binding partners of YAP\/TAZ","volume":"51","author":"MK Kim","year":"2018","journal-title":"BMB Rep"},{"issue":"1","key":"ppat.1013906.ref034","article-title":"The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb\/RNAPII\/TAR complex promoting HIV transcription elongation","volume":"120","author":"C Li","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1013906.ref035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.it.2022.11.003","article-title":"New insights into transcription elongation control of HIV-1 latency and rebound","volume":"44","author":"U Mbonye","year":"2023","journal-title":"Trends Immunol"},{"issue":"5","key":"ppat.1013906.ref036","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.gpb.2017.05.003","article-title":"Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat","volume":"15","author":"S Eilebrecht","year":"2017","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1","key":"ppat.1013906.ref037","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41467-018-07022-2","article-title":"Reciprocal inhibition of YAP\/TAZ and NF-\u03baB regulates osteoarthritic cartilage degradation","volume":"9","author":"Y Deng","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"ppat.1013906.ref038","article-title":"SHMT2 and the BRCC36\/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy","volume":"14","author":"M Xu","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1013906.ref039","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/2045-3701-4-61","article-title":"Modulation of the stability and activities of HIV-1 Tat by its ubiquitination and carboxyl-terminal region","volume":"4","author":"L Zhang","year":"2014","journal-title":"Cell Biosci"},{"issue":"1","key":"ppat.1013906.ref040","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-021-22987-3","article-title":"YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3","volume":"12","author":"D Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1013906.ref041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","article-title":"Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation","volume":"137","author":"P Xu","year":"2009","journal-title":"Cell"},{"issue":"13","key":"ppat.1013906.ref042","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.micinf.2005.06.003","article-title":"Decoding Tat: the biology of HIV Tat posttranslational modifications","volume":"7","author":"C Hetzer","year":"2005","journal-title":"Microbes Infect"},{"issue":"2","key":"ppat.1013906.ref043","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00430-019-00583-z","article-title":"Genetic variation and function of the HIV-1 Tat protein","volume":"208","author":"C Spector","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"ppat.1013906.ref044","doi-asserted-by":"crossref","first-page":"103985","DOI":"10.1016\/j.ebiom.2022.103985","article-title":"Novel role of UHRF1 in the epigenetic repression of the latent HIV-1","volume":"79","author":"R Verdikt","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"ppat.1013906.ref045","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02222-23","article-title":"CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells","volume":"15","author":"U Rathore","year":"2024","journal-title":"mBio"},{"issue":"3","key":"ppat.1013906.ref046","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/mc.23493","article-title":"UHRF1 plays an oncogenic role in small cell lung cancer","volume":"62","author":"J Hou","year":"2023","journal-title":"Mol Carcinog"},{"issue":"8","key":"ppat.1013906.ref047","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ncb1023","article-title":"A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter","volume":"5","author":"V Br\u00e8s","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"11","key":"ppat.1013906.ref048","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tibs.2009.07.002","article-title":"CRL4s: the CUL4-RING E3 ubiquitin ligases","volume":"34","author":"S Jackson","year":"2009","journal-title":"Trends Biochem Sci"},{"issue":"24","key":"ppat.1013906.ref049","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/emboj\/cdf669","article-title":"Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF","volume":"21","author":"V Br\u00e8s","year":"2002","journal-title":"EMBO J"},{"issue":"11","key":"ppat.1013906.ref050","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1021\/acsinfecdis.3c00218","article-title":"Bcl-2 Antagonist Obatoclax Reactivates Latent HIV-1 via the NF-\u03baB Pathway and Induces Latent Reservoir Cell Apoptosis in Latently Infected Cells","volume":"9","author":"C Zhou","year":"2023","journal-title":"ACS Infect Dis"},{"key":"ppat.1013906.ref051","doi-asserted-by":"crossref","first-page":"101181","DOI":"10.1016\/j.drup.2024.101181","article-title":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","volume":"78","author":"C-J Shi","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"12","key":"ppat.1013906.ref052","article-title":"A new small-molecule compound, Q308, silences latent HIV-1 provirus by suppressing Tat- and FACT-mediated transcription","volume":"65","author":"CL Zhou","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ppat.1013906.ref053","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2144\/000113519","article-title":"An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio","volume":"49","author":"Y Kodama","year":"2010","journal-title":"Biotechniques"},{"issue":"44","key":"ppat.1013906.ref054","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027428","article-title":"Identification of HIV-1-specific cascaded microRNA-mRNA regulatory relationships by parallel mRNA and microRNA expression profiling with AIDS patients after antiviral treatment","volume":"100","author":"F Shen","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:42:49Z","timestamp":1769798569000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013906"}},"subtitle":[],"editor":[{"given":"Yong-Hui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013906","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}